CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: The results showed that miR-181a expression was significantly lower in CML CD34+ cells (n = 11) than in normal bone marrow (NBM) CD34+ cells (n = 10) (Fig. 1A).